AbbVie (ABBV) vs Eli Lilly (LLY)
AbbVie (ABBV) and Eli Lilly (LLY) side by side: both in Healthcare, both listed on New York Stock Exchange. Eli Lilly is the larger of the two by approximate market capitalization (about 2.4×).
| Field | AbbVie | Eli Lilly |
|---|---|---|
| Legal name | AbbVie Inc. | Eli Lilly and Company |
| Ticker | ABBV | LLY |
| Exchange | New York Stock Exchange XNYS | New York Stock Exchange XNYS |
| Jurisdiction | United States | United States |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Market cap ≈ | $451.5bn | $1.1tn |
| Founded | 2013 | 1876 |
| Reporting currency | USD | USD |
| LEI | FR5LCKFTG8054YNNRU85 | FRDRIPF3EKNDJ2CQJL29 |
| ISIN | US00287Y1091 | US5324571083 |
| FIGI | BBG0025Y4RZ3 | BBG001S5STL8 |
| Index membership | S&P 500 | S&P 500 |
| Held by (covered funds) | — | 1 |
AbbVie
Large pharmaceutical company spun off from Abbott in 2013, with immunology blockbusters Skyrizi and Rinvoq succeeding Humira, plus the Allergan aesthetics portfolio (Botox).
Eli Lilly
Pharmaceutical maker; GLP-1 metabolic drugs (Mounjaro, Zepbound), oncology and neuroscience.
What they share
Same indices: S&P 500
Market caps are computed from each issuer's own filed share count times the close on 2026-08-28, not copied from a vendor; LEI from GLEIF (CC0), ISIN read from each issuer's own primary listing document with its ISO 6166 check digit validated, FIGI from OpenFIGI, MIC from the ISO 10383 registry — full provenance on Sources. Not real-time, not investment advice. Both sides as data: /api/v1/companies/abbvie · /api/v1/companies/eli-lilly